Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
May 21, 2022
Recording Temperature with Magnetic Supraparticles
Jakob Reichstein, Stephan Müssig, Hannes Bauer, et al.
AAPS Pharmscitech
|
June 24, 2020
Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch
Josip Matić, Amrit Paudel, Hannes Bauer, et al.
International Journal of Pharmaceutics
|
December 12, 2022
Pharmaceutical hot melt extrusion process development using QbD and digital twins
Josip Matić, Milica Stanković-Brandl, Hannes Bauer, et al.
Antibodies (Basel, Switzerland)
|
December 22, 2022
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, et al.
Vaccines
|
September 28, 2023
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
Stefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Advanced Materials (Deerfield Beach, Fla.)
|
May 21, 2022
Recording Temperature with Magnetic Supraparticles
Jakob Reichstein, Stephan Müssig, Hannes Bauer, et al.
AAPS Pharmscitech
|
June 24, 2020
Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch
Josip Matić, Amrit Paudel, Hannes Bauer, et al.
International Journal of Pharmaceutics
|
December 12, 2022
Pharmaceutical hot melt extrusion process development using QbD and digital twins
Josip Matić, Milica Stanković-Brandl, Hannes Bauer, et al.
Antibodies (Basel, Switzerland)
|
December 22, 2022
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, et al.
Vaccines
|
September 28, 2023
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
Stefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Page
of 1